logo

For the Inventor, By the Inventor

Aachen, Germany

Stefanie Frosch

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:

goldMedal12 out of 357 
 
Gruenenthal Gmbh
 patents
silverMedal1 out of 4 
 
Park Therapeutics, Inc.
 patents

Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11311504 - Pharmaceutical composition comprising (1R,4R)-6'- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol (2022-04-26),
2. 10328055 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants (2019-06-25),
3. 10076510 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative (2018-09-18),
4. 9855286 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component (2018-01-02),
5. 9629825 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid (2017-04-25),
6. 9345689 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant (2016-05-24),
7. 9320729 - Pharmaceutical composition comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative (2016-04-26),
8. 9320725 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid (2016-04-26),
9. 9308196 - Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam (2016-04-12),
10. 8912226 - Pharmaceutical composition comprising (1r,4r) -6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR (2014-12-16),
11. 7183274 - Piperidine-2,6-diones heterocyclically substituted in the 3-position (2007-02-27),
12. 6656937 - Substituted glutarimides and their use as inhibitors of IL-12 production (2003-12-02),
13. 6080742 - Substituted benzamides (2000-06-27),

Title: The Innovative Journey of Stefanie Frosch

Introduction

Stefanie Frosch, an influential inventor based in Aachen, Germany, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 13 patents, her work focuses on developing novel pharmaceutical compositions aimed at addressing various medical needs.

Latest Patents

Among her most recent patents are two notable inventions that highlight her expertise in pharmaceutical compositions. The first patent involves a composition that combines (1R,4R)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine with paracetamol or propacetamol. This invention addresses a need for effective analgesics through enhanced pharmacological activity. The second patent involves a similar composition, where the first pharmacologically active ingredient is also (1R,4R)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine, combined with an antidepressant to provide a dual-action solution for patients facing both pain and mood disorders.

Career Highlights

Stefanie has gained extensive experience through her work with leading pharmaceutical companies such as Grünenthal GmbH and Park Therapeutics, Inc. Her innovative approach and dedication to research have greatly advanced the field of pharmacology, with her patents reflecting her commitment to developing effective therapeutic solutions.

Collaborations

Throughout her career, Stefanie has collaborated with distinguished professionals like Klaus Linz and Klaus Schiene. These partnerships have contributed significantly to her research endeavors and the success of her patented inventions.

Conclusion

In summary, Stefanie Frosch stands out as a prominent inventor whose work has substantially impacted the pharmaceutical industry. Her 13 patents reveal her innovative mindset and dedication to improving healthcare outcomes, making her a valuable contributor to the field. Her ongoing work promises to bring further advancements in medical treatments, benefiting both healthcare professionals and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…